SCHEMBL22609316

SCHEMBL22609316

COC(=O)c1noc(C)c1Nc1ccc(C#N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CISD2 Q8N5K1 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ THRB P10828 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609264 0.96 RXFP1 (0.43) DHODHRXFP1ALOX15HSD17B10CISD2
SCHEMBL22609268 0.87 DHODH (0.43) DHODHRXFP1ALOX15HSD17B10TP53
SCHEMBL22609248 0.84 ALDH1A1 (0.38) HSD17B10MAPTKMT2AMEN1ALDH1A1
SCHEMBL23453717 0.84 DHODH (0.41) DHODHRXFP1ALOX15HSD17B10TP53
SCHEMBL22609336 0.83 POLB (0.48) DHODHRXFP1ALOX15HSD17B10TP53
SCHEMBL22609245 0.83 MAPT (0.45) DHODHRXFP1TP53POLBMAPT
SCHEMBL20530970 0.77 GSK3B (0.45) DHODHRXFP1CISD2POLBMAPT
SCHEMBL22609335 0.77 HTT (0.45) TP53POLBMAPTKMT2AMEN1
SCHEMBL18091779 0.74 TP53 (0.44) RXFP1CISD2TP53POLBMAPT
SCHEMBL23453703 0.73 ALDH1A1 (0.47) ALOX15HSD17B10POLBIDO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
EP-3731840-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF Orfan Biotech Inc. (US) 2020-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS DHODH 123/4885RXFP1 2736/4885ALOX15 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback